FDA Drug recall D-0296-2016
LiDa DAIDAIHUA (also packaged as LiDa DAIDAIHUAJIAONANG), capsules, packaged in 1.6oz box 30 capsules per box, Kunming Dali Industry & Trad…
- FDA Drug
- Class I
- terminated
- Published 2015-11-25
On 2015-11-25 the FDA classified a Class I recall of LiDa DAIDAIHUA (also packaged as LiDa DAIDAIHUAJIAONANG), capsules, packaged in 1.6oz box 30 capsules per box, Kunming Dali Industry & Trad… by Blue Square Market, citing marketed Without An Approved NDA/ANDA: presence of undeclared Sibutramine and Phenolphthalein.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0296-2016 |
| Classification | Class I |
| Status | terminated |
| Initiated | 2015-08-06 |
| Published | 2015-11-25 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | Blue Square Market |
| Distribution | US |
Product
LiDa DAIDAIHUA (also packaged as LiDa DAIDAIHUAJIAONANG), capsules, packaged in 1.6oz box 30 capsules per box, Kunming Dali Industry & Trade Co., Ltd
Reason
Marketed Without An Approved NDA/ANDA: presence of undeclared Sibutramine and Phenolphthalein.
Identifiers
| code_info | all lots |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0296-2016%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.